Our findings align with previous studies that emphasize the importance of multitarget approaches in AD treatment. Different authors have demonstrated that compounds targeting multiple pathways exhibited enhanced therapeutic effects, supporting the utility of AlzyFinder in identifying such candidates , highlighting the important role of in silico methods in multi-target directed ligands design 3 .